EGFR and androgen insensitivity syndrome: In AIS, the proportion of tumors detected with various co-occurring mutations, or co-occurrence fraction, were similar for EGFR 20ins, 19del, and L858R (20.0% vs. 14.3% vs. 25.0%, P = 0.802; Fig. 4A).